Search results for "Acute thrombosi"

showing 3 items of 3 documents

Magnetic resonance direct thrombus imaging for pre-operative assessment of acute thrombosis in chronic thromboembolic pulmonary hypertension

2018

Adultmedicine.medical_specialtyHypertension PulmonaryEndarterectomyPulmonary ArteryInternal medicinemedicineMedical imagingHumansThrombusThromboembolic pulmonary hypertensionmedicine.diagnostic_testbusiness.industryThrombosisMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingThrombosisPre operativeTreatment OutcomeChronic DiseasePreoperative PeriodCardiologyChronic thromboembolic pulmonary hypertensionAcute thrombosisPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Combination of high bolus dose of tirofiban with half dose thrombolytics for the treatment of subacute stent thrombosis

2005

Acute stent thrombosis is rare and it is usually related to complications during the procedure. Subacute thrombosis is far more common and is associated with a high incidence of acute myocardial infarction and death. Restoration of flow by thrombolysis, emergency bypass surgery or emergency percutaneous transluminal coronary angioplasty (PTCA) has had only limited success with respect to myocardial salvage. We report the case of a patient who suffered from recurrent subacute stent thrombosis, in whom administration of tirofiban at high-dose bolus in association with a half dose of recombinant tissue plasminogen activator succeeded in restoring normal myocardial flow and stable clinical cond…

Malemedicine.medical_specialtyPercutaneous transluminal coronary angioplastymedicine.medical_treatmentMyocardial InfarctionThrombolysiCoronary AngiographyRisk AssessmentBolus (medicine)Fibrinolytic AgentsCoronary CirculationAcute thrombosiInternal medicineStentmedicineHumanscardiovascular diseasesStent thrombosisMyocardial infarctionAngioplasty Balloon CoronaryVascular PatencyAgedDose-Response Relationship Drugbusiness.industryCoronary ThrombosisGeneral MedicineTirofibanThrombolysismedicine.diseaseThrombosisSurgeryTirofibanBypass surgeryAcute DiseaseCardiologyTyrosineDrug Therapy CombinationStentsCardiology and Cardiovascular MedicinebusinessFollow-Up Studiesmedicine.drugActa Cardiologica
researchProduct

Antiplatelet Therapy in Marathon Runners: More Harm than Benefits?

2013

We read with interest the article by Arthur J. Siegel, who recently concluded that prophylactic aspirin for primary prevention of cardiac events in marathon runners may be a viable approach for lowering the global risk of cardiovascular events in these subjects. Although there is a credible hysiological basis for supporting this provocative suggesion, and the use of nonsteroidal anti-inflammatory drugs is requent in athletes, there are, however, some issues that hould be considered, and which would globally overwhelm he hypothetical advantages of antiplatelet therapy in this eculiar setting. First, there is no controlled, randomized study that has efinitely proven the existence of any poten…

medicine.medical_specialtyMarathon runningantiplatelet therapylaw.inventionchemistry.chemical_compoundRandomized controlled triallawantiplatelet therapy; marathon race; harmAntithromboticmedicineAspirinNonsteroidalbiologyAthletesbusiness.industryGeneral Medicinebiology.organism_classificationmarathon raceHarmchemistryPhysical therapyAcute thrombosisbusinesshuman activitiesharmmedicine.drugThe American Journal of Medicine
researchProduct